payout ratio8 % 80.79 97.77 309.91 Interest Bearing Debt to equity ratio9 times 1.39 1.38 2.04 Specific Ratio for Our Business1 Cash collection from NPL management business to net NPLs10 % 12.83 14.55

- 747.8 - 679.6 10.0% Selling expenses - 20.1 - 15.9 26.3% Administrative expenses - 44.0 - 45.0 -2.2% Finance costs - 7.9 - 11.4 -30.3% Profit for the period 42.6 131.7 -67.7% Net Profit 4.9% 14.5% EBITDA

% Net Profit 1.3% 6.7% EBITDA (MB) 9.0 20.8 -56.9% EBITDA (%) 5.1% 11.7% Earnings per share (Baht) - 0.02 -100.0% Remark : EBITDA = Profit before finance costs, income tax, Depreciation and Amortization

incurred from deferred tax. This extra transaction was included in year ended 2017 financial statement for the net amount of THB 24 million. Revenue from Hospital Operations Revenue from hospital operations

% Cost of sales - 191.6 - 160.8 -19.1% Selling expenses - 4.7 - 4.0 -17.8% Administrative expenses - 10.1 - 11.9 15.5% Finance costs - 2.8 - 3.0 5.3% Profit for the period 12.7 20.6 -38.5% Net Profit 5.7

3122.1% Cost of sales - 151.2 - 216.3 30.1% Selling expenses - 5.3 - 5.4 2.7% Administrative expenses - 9.6 - 10.7 10.8% Finance costs - 3.1 - 2.8 -9.7% Profit for the period 17.2 5.3 222.9% Net Profit 9.1

Company’s subsidiaries for the second quarter of 2018, the consolidated financial statement showed a net profit of 119.9 million baht, which was a lower from the second quarter of 2017 3.9 percent. This

profit from associates and JV 62 118 (56) -47.5% Net profit attributable to equity holders 302 243 59 +24.3% 99 หมู่ที 1 นิคมอุตสาหกรรมไฮเทค ตาํบลบา้นเลน อาํเภอบางปะอิน จงัหวดัพระนครศรีอยธุยา 13160

percent. Net Profit At the end of 3Q 2018, the Company and its subsidiaries earn the net profit in the amount of THB 148 million, which is increased from the same period of the previous year by THB 4

1Q18 compare to in 1Q17, the Company EBITDA slightly decreased from 11.5 percent to 10.1 percent. Net Profit At the end of 1Q18, the Company and its subsidiaries earn the net profit in the amount of THB